Brctherapeutics
1 known investors
BRC Therapeutics develops prescription cannabinoid-based medicines targeting pain, neurological, and inflammatory conditions in chronic illnesses. Its pipeline includes investigational products in clinical trials for Complex Regional Pain Syndrome (CRPS) and Aromatase Inhibitor-Induced Arthralgia (AIIA), and the company is registered with the DEA.</parameter> <parameter name="founders">[]
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Brctherapeutics do?
- BRC Therapeutics develops prescription cannabinoid-based medicines targeting pain, neurological, and inflammatory conditions in chronic illnesses. Its pipeline includes investigational products in clinical trials for Complex Regional Pain Syndrome (CRPS) and Aromatase Inhibitor-Induced Arthralgia (AIIA), and the company is registered with the DEA.</parameter> <parameter name="founders">[]
- Who are Brctherapeutics's investors?
- Brctherapeutics's investors include Delta Emerald Ventures.